SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-029540
Filing Date
2019-06-03
Accepted
2019-06-03 18:33:31
Documents
1
Period of Report
2019-05-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv522951_4.html 4  
1 OWNERSHIP DOCUMENT tv522951_4.xml 4 13952
  Complete submission text file 0001144204-19-029540.txt   16329
Mailing Address 1 DEXCEL STREET OR AKIVA L3 30600000
Business Address 1 DEXCEL STREET OR AKIVA L3 30600000 972-4-636404
Dexxon Holdings Ltd. (Reporting) CIK: 0001636684 (see all company filings)

State of Incorp.: L3 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38667 | Film No.: 19874800

Mailing Address 1 DEXCEL STREET OR AKIVA L3 30600000
Business Address
Oren Dan (Reporting) CIK: 0001636701 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38667 | Film No.: 19874802

Mailing Address 1 DEXCEL STREET OR AKIVA L3 3060000
Business Address 1 DEXCEL STREET OR AKIVA L3 3060000 97246364040
Dexcel Pharma Technologies Ltd. (Reporting) CIK: 0001720007 (see all company filings)

State of Incorp.: L3 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38667 | Film No.: 19874801

Mailing Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617
Business Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Issuer) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations